Evidence map›Paper›PMID 26308617›Full record

ArticlePloS one2015

A New Imaging Platform for Visualizing Biological Effects of Non-Invasive Radiofrequency Electric-Field Cancer Hyperthermia.

Stuart J Corr, Sabeel Shamsudeen, Leoncio A Vergara, Jason Chak-Shing Ho, Matthew J Ware, Vazrik Keshishian, Kenji Yokoi, David J Savage, Ismail M Meraz, Warna Kaluarachchi and 9 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Stuart J CorrDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America; Department of Chemistry, Rice University, Houston, TX, United States of America; Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Sabeel ShamsudeenDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America; Department of Biomedical Engineering, University of Houston, TX, United States of America.
Leoncio A VergaraDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America.
Jason Chak-Shing HoDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America.
Matthew J WareDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America.
Vazrik KeshishianDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America.
Kenji YokoiDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America.
David J SavageDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America.
Ismail M MerazDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America.
Warna KaluarachchiDepartment of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Brandon T CisnerosDepartment of Chemistry, Rice University, Houston, TX, United States of America; Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Mustafa RaoofDepartment of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America.
Duy Trac NguyenDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America; Department of Biomedical Engineering, University of Houston, TX, United States of America.
Yingchun ZhangDepartment of Biomedical Engineering, University of Houston, TX, United States of America.
Lon J WilsonDepartment of Chemistry, Rice University, Houston, TX, United States of America.
Huw SummersDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America; Centre for Nanohealth, College of Engineering, Swansea University, Swansea, Wales, United Kingdom.
Paul ReesDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America; Centre for Nanohealth, College of Engineering, Swansea University, Swansea, Wales, United Kingdom; The Broad Institute, Cambridge, MA, United States of America.
Steven A CurleyDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America; Department of Mechanical Engineering and Materials Science, Rice University, Houston, TX, United States of America.
Rita E SerdaDepartment of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
TRANS-NETWORK PROJECTSU54CA143837 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CURLEY, STEVEN ALAN · 2009 to 2014
$10.8M
Center for Clinical and Translational Sciences (CCTS)TL1TR000369 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$1.9M
BCM Oncology Scholars Training ProgramT32CA174647 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LIN, WEEI-CHIN · 2014 to 2018
$1.2M
NCATS NIH HHS TL1 TR000369NCATS NIH HHS TL1TR000369NCATS NIH HHS UL1 TR000371NCATS NIH HHS UL1TR000371NCI NIH HHS CA016672NCI NIH HHS P30 CA016672NCI NIH HHS T32 CA174647NCI NIH HHS U54 CA143837NCI NIH HHS U54CA143837
6 · The paper itself

Abstract

Herein, we present a novel imaging platform to study the biological effects of non-invasive radiofrequency (RF) electric field cancer hyperthermia. This system allows for real-time in vivo intravital microscopy (IVM) imaging of radiofrequency-induced biological alterations such as changes in vessel structure and drug perfusion. Our results indicate that the IVM system is able to handle exposure to high-power electric-fields without inducing significant hardware damage or imaging artifacts. Furthermore, short durations of low-power (< 200 W) radiofrequency exposure increased transport and perfusion of fluorescent tracers into the tumors at temperatures below 41°C. Vessel deformations and blood coagulation were seen for tumor temperatures around 44°C. These results highlight the use of our integrated IVM-RF imaging platform as a powerful new tool to visualize the dynamics and interplay between radiofrequency energy and biological tissues, organs, and tumors.

Indexed as

Diagnostic ImagingHyperthermia, InducedRadio WavesAlgorithmsAnimalsFemaleFluorescent Antibody TechniqueFluorescent DyesIntravital MicroscopyMammary Neoplasms, AnimalMiceTissue DistributionFluorescent Dyes

Identifiers

PMID26308617
PMCPMC4550384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.